Resources

Our news

QSM Quantitative Susceptibility Mapping

Dr. Stephane ROCHE, PhD, Dr. Ludovic de ROCHEFORT, PhD; Novembre 2022 Definition: QSM (Quantitative …

Medical Imaging Innovation Award

Ventio receives the Medical Imaging Innovation Award (JFR, Paris, 2022) The 70th edition of the Jour…

QMR Lucca workshop on QSM and MRI

QMR Joint Workshop on MR phase, magnetic susceptibility and electrical properties mapping Lucca (Ita…

World Alzheimer’s Day 2022

Ventio participates to the follow-up of Alzheimer’s disease patients by offering a patented, i…

Jacques Badagbon’s new professional skills on ISO27001 implementation

Jacques Badagbon’s new professional skills on ISO27001 implementation Last May, Jacques had su…

Ventio – innovation in digital health

Indeed, the company has been hosted by Marseille Innovation for one year and has benefited from the …

Pseudonymization and anonymization: what rules apply to our health data?

Pseudonymization and anonymization: what rules apply to our health data? 2142 zettabytes. This is th…

Your partner for Quantitative Susceptibility Mapping in Europe

Your partner for Quantitative Susceptibility Mapping in Europe QSM is an innovative patented techniq…

Ventio is proud to welcome Miguel Guevara in the QSM4SENIOR project!

Ventio is proud to welcome Miguel Guevara in the QSM4SENIOR project! Miguel joined the project-team …

Access control and authentification: threats and solutions

Access control and authentification: threats and solutions In terms of IT security, user’s man…

Quantum programming: a major technological challenge

Quantum programming: a major technological challenge Ventio is acquiring expertise in quantum progra…

Quantum attacks: Ventio protects sensitive environments thanks to post-quantum encryption

Protecting sensitive information and resisting quantum attacks: Ventio stays ahead of the curve and …

QSM4SENIOR: the gold standard for rusting brains

QSM4SENIOR: the gold standard for rusting brains Ventio and NeuroSpin are partners in a recently-sel…

Ventio becomes a member of the AFCDP

Ventio becomes a member of the French Association of Data Protection Officers (AFCDP) and strengthen…

Ventio synthesizes the new CNIL guidelines on health data warehouses

Deciphering the new CNIL guidelines on health data warehouses, Ventio gives you its synthesis! On No…

The security of cloud services

The security of cloud services In France, the national Information Systems Security agency (ANSSI) n…

Container technology: benefits and security

Container technology: benefits and security The boom in cloud computing has quickly led to the devel…

Healthcare data security: is your data sufficiently protected?

Healthcare data security: is your data sufficiently protected? The French supervisory authority (CNI…


Publications of the field

QSM Quantitative Susceptibility Mapping

Dr. Stephane ROCHE, PhD, Dr. Ludovic de ROCHEFORT, PhD; Novembre 2022 Definition: QSM (Quantitative …

QSM as an imaging biomarker for Alzheimer’s disease

Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectation…

Phenotypic and genetic associations of quantitative magnetic susceptibility

Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imag…

How does QSM perform in detecting this process?

Brain pathological changes during neurodegenerative diseases and their identification methods: How d…

FDA-clearance

510(k) Premarket Notification Device Classification Name system, nuclear magnetic resonance imaging …

QSM Patent

Accurate quantification of magnetic susceptibility in molecular mri Inventor: Yi Wang, Ludovic De Ro…

SENIOR cohort : imaging the aging brain

Imaging the aging brain: study design and baseline findings of the SENIOR cohort Alexa Haeger, Jean-…

Clinical Integration of Automated Processing for Brain QSM

Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Si…

Clinical Integration of QSM into Neurosurgical Practice

Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosur…

APP Ab38 Ab40 in FTD

Decreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia Gabelle, Audr…

Quantitative susceptibility map reconstruction

Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Val…

sAPP & Abeta in CSF

Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in…

Preanalytical guideline

Preanalytical guidelines for clinical proteomics investigation of biological fluids S Lehmann, S. Ro…

Biomarkers in CSF

Les marqueurs biologiques protéiques du liquide céphalorachidien : caractéristiques et implications …

Autoantibody in CSF

Auto-antibody profiling on high-density protein microarrays for biomarker discovery in the cerebrosp…

Quantitative MR susceptibility mapping

Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnet…

Clinical proteomics in CSF

Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers Stéphane Roc…

end of page